Abstract
Medicaid program criteria for accessing hepatitis C treatment are changing. Medicaid drug utilization data from 2014 to 2016 show that programs that have relaxed their criteria have seen significant increases in treatment utilization, as have states with Medicaid expansions.
Publication types
-
Research Support, N.I.H., Extramural
MeSH terms
-
Antiviral Agents / administration & dosage
-
Antiviral Agents / classification
-
Antiviral Agents / therapeutic use*
-
Hepacivirus
-
Hepatitis C, Chronic / drug therapy*
-
Hepatitis C, Chronic / epidemiology
-
Humans
-
Medicaid / legislation & jurisprudence*
-
United States